Topical salicylic acid interferes with UVB therapy for psoriasis

Area of Science:

• Dermatology
• Photobiology
• Cosmetic Science

Background:

• Salicylic acid is a common topical treatment for psoriasis.
• It shares chemical similarities with para-aminobenzoic acid.
• Preliminary in vitro data suggested potential UVB absorption properties.

Purpose of the Study:

• To investigate the in vivo UVB filtering capacity of salicylic acid.
• To evaluate the duration of photoprotection offered by salicylic acid.
• To assess the impact of salicylic acid on the therapeutic efficacy of emollients in psoriasis treatment.

Main Methods:

• In vitro assessment of UVB absorption.
• Clinical evaluation of photoprotection duration post-application.
• A prospective, randomized, double-blind, left-right comparison study in psoriasis patients comparing emollients with and without salicylic acid.

Main Results:

• Salicylic acid demonstrated a clinically significant UVB filter effect.
• Photoprotection duration exceeded 12 hours, sometimes surpassing 24 hours.
• The inclusion of salicylic acid in emollients significantly reduced the rate of psoriasis lesion clearing.

Conclusions:

• Salicylic acid possesses effective UVB filtering capabilities with extended duration.
• Despite its photoprotective properties, salicylic acid inclusion in topical treatments may impede psoriasis clearance.
• Further research is warranted to balance the photoprotective benefits against potential therapeutic drawbacks in psoriasis management.